On June 24, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. unveiled an ambitious vision during a House committee meeting: to have every American using a wearable h...
In a groundbreaking development for the medical community, a recent study has unveiled a potential cure for severe type 1 diabetes through a revolutionary stem cell treatment.
The...
The pervasive hum of traffic, the roar of airplanes overhead, and the relentless clatter of urban life are more than mere annoyances—they are a public health crisis affecting milli...
A startling revelation has emerged from the world of food safety research, challenging long-held assumptions about the purity of beverages packaged in glass bottles.
According to...
In a groundbreaking development that could reshape the intersection of environmental sustainability and pharmaceutical production, scientists at the University of Edinburgh have ha...
The frontier of space is no longer just a realm for astronauts and satellites; it has become a promising laboratory for medical breakthroughs, particularly in the fight against can...
The rapid integration of artificial intelligence into healthcare has sparked both optimism and concern, with chatbots emerging as a potential tool for patient self-assessment.
How...
In a dramatic turn of events, Anne Wojcicki, co-founder and former CEO of 23andMe, has emerged victorious in a bankruptcy auction for the genetic testing company she once led.
Her...
In the fast-paced world of healthcare, project management can often feel like a daunting task. Keeping track of patient records, managing appointments, and...
Neuralink, the brain-computer interface company founded by Elon Musk, has just secured a staggering $650 million in a Series E funding round, marking a sig...
In the ever-evolving intersection of technology and human performance, a groundbreaking innovation has emerged that could redefine how we monitor mental strain in high-stakes envir...
Sheba Medical Center, ranked by Newsweek as one of the top ten hospitals in the world, is redefining healthcare through its innovative use of artificial in...
Weight management and diabetes treatment in the United States has undergone a seismic shift in recent years, driven by the meteoric rise of GLP-1 receptor agonist drugs. According...
Regeneron Pharmaceuticals’ announced acquisition of 23andMe for $256 million marks a pivotal moment in the intersection of biotechnology, consumer genomics, and data-driven persona...
On May 16, 2025, the U.S. Food and Drug Administration granted clearance to Japan-based Fujirebio for its blood test designed to aid in the diagnosis of Alzheimer’s disease—a pivot...
WebProNews is an iEntry Publication
